Board Meeting12 Jun 2026, 05:41 pm
Shree Ganesh Biotech Closes Trading Window for Q1 FY27 Results
AI Summary
Shree Ganesh Biotech (India) Ltd has announced the closure of its trading window for dealing in the company's securities. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The trading window will be shut from Wednesday, July 1, 2026, until 48 hours after the declaration of the unaudited financial results for the first quarter ended June 30, 2026. The date for the board meeting to approve these results will be communicated separately.
Key Highlights
- Trading window closed from July 1, 2026.
- Closure is for Q1 FY27 unaudited financial results.
- Window reopens 48 hours post-results announcement.
- Board meeting date for results approval to be announced later.
Price Impact
More from SHREEGANES